Plasma Cell Tumors in Hematological Classifications of 2022: WHO-HAEM5 (WHO, 5th edition) and ICC (International Consensus Classification). A Clinician’s View

In 2022, the hematological community was faced with a rather non-trivial event of simultaneous publication of two competitive classifications of hematopoietic and lymphoid tumors drawn up by different teams of the international leading experts. During the last 20 years, the generally recognized stan...

Description complète

Détails bibliographiques

Auteur principal:	Sergei Vyacheslavovich Semochkin
Format:	Artigo
Langue:	Russo
Publié:	Practical Medicine Publishing House 2024-04-01
Collection:	Клиническая онкогематология
Sujets:	multiple myeloma monoclonal gammopathy of undetermined significance cold agglutinin disease lymphoplasmacytic lymphoma al amyloidosis
Accès en ligne:	https://bloodjournal.ru/index.php/coh/article/view/72
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!